<?php
/**
 * Synthesis Composer Service
 *
 * Stage 3: Composes AI-powered synthesis reports from canonical NB datasets.
 *
 * This service was extracted from synthesis_engine.php during M1T5-8 restoration.
 * It handles the core compose_synthesis_report() logic that generates 15-section
 * intelligence narratives using OpenAI GPT-4.
 *
 * Pipeline: raw_collector ‚Üí canonical_builder ‚Üí synthesis_composer ‚Üí qa_engine
 *
 * @package    local_customerintel
 * @copyright  2025 CustomerIntel
 * @license    http://www.gnu.org/copyleft/gpl.html GNU GPL v3 or later
 */

namespace local_customerintel\services;

defined('MOODLE_INTERNAL') || die();

require_once(__DIR__ . '/voice_enforcer.php');
require_once(__DIR__ . '/qa_scorer.php');
require_once(__DIR__ . '/telemetry_logger.php');

// NOTE: CitationManager class is defined in synthesis_engine.php
// We use the parent engine's CitationManager, not a duplicate

/**
 * Synthesis Composer - Stage 3 Service
 */
class synthesis_composer {

    /** @var object $synthesis_engine Reference to parent synthesis_engine for helper methods */
    private $synthesis_engine;

    /**
     * Constructor
     *
     * @param object $synthesis_engine Parent synthesis_engine instance
     */
    public function __construct($synthesis_engine) {
        $this->synthesis_engine = $synthesis_engine;
    }

    /**
     * Compose synthesis report from canonical NB dataset
     *
     * This is the core Stage 3 function that:
     * 1. Loads canonical dataset
     * 2. Generates 15 AI-powered narrative sections
     * 3. Assembles markdown report
     * 4. Calculates QA scores
     * 5. Saves synthesis_final_bundle artifact
     *
     * @param int $runid Run ID
     * @return bool Success status
     */
    public function compose_synthesis_report($runid) {
        global $DB;

        // M2 Task 0.1: Set status to 'processing' at start of synthesis
        $DB->update_record('local_ci_run', (object)[
            'id' => $runid,
            'status' => 'processing',
            'timemodified' => time()
        ]);

        // Phase timing and trace
        $this->log_trace($runid, 'synthesis', 'Synthesis composer started - status set to processing', ['runid' => $runid]);
        $this->start_phase_timer($runid, 'synthesis_composition');

        try {
            // Step 1: Load canonical dataset
            $artifact = $DB->get_record('local_ci_artifact', [
                'runid' => $runid,
                'artifacttype' => 'canonical_nb_dataset'
            ]);

            if (!$artifact) {
                throw new \Exception('Canonical dataset not found for runid: ' . $runid);
            }

            $canonical = json_decode($artifact->jsondata, true);
            if (json_last_error() !== JSON_ERROR_NONE) {
                throw new \Exception('Failed to decode canonical dataset: ' . json_last_error_msg());
            }

            $metadata = $this->get_or($canonical, 'metadata', []);
            $nb_data = $this->get_or($canonical, 'nb_data', []);

            $this->log_trace($runid, 'synthesis', 'Canonical dataset loaded', [
                'nb_count' => count($nb_data),
                'metadata_keys' => array_keys($metadata)
            ]);

            // Step 2: Initialize CitationManager through parent engine
            $citation_mgr = $this->synthesis_engine->create_citation_manager();

            // Step 3: Define authoritative NB to section mapping
            $nb_mapping = [
                'NB1' => 'Company Overview',
                'NB2' => 'Financial Performance',
                'NB3' => 'Leadership & Governance',
                'NB4' => 'Strategic Initiatives',
                'NB5' => 'Operational Risks',
                'NB6' => 'Technology & Digital',
                'NB7' => 'Market & Competitive Positioning',
                'NB8' => 'Organizational Structure & Culture',
                'NB9' => 'Stakeholders & Partnerships',
                'NB10' => 'ESG / Sustainability',
                'NB11' => 'Innovation & Collaboration',
                'NB12' => 'Customer & Market Insights',
                'NB13' => 'Emerging Trends & Strategic Outlook',
                'NB14' => 'Growth Opportunities',
                'NB15' => 'Engagement Pathways & Closing Summary'
            ];

            // Step 4: Build Executive Summary using existing infrastructure
            $this->log_trace($runid, 'synthesis', 'Generating executive summary');

            // Prepare inputs for draft_executive_insight
            $exec_inputs = [
                'nb' => $nb_data,
                'company_source' => isset($metadata['source_company']) ? (object)$metadata['source_company'] : null,
                'company_target' => isset($metadata['target_company']) ? (object)$metadata['target_company'] : null
            ];

            $patterns = $this->detect_patterns($exec_inputs);
            $exec_result = $this->draft_executive_insight($exec_inputs, $patterns, $citation_mgr);
            $exec_summary = $this->get_or($exec_result, 'text', 'Executive summary pending.');

            // Apply voice artifact removal to executive summary
            $exec_summary = $this->remove_voice_artifacts($exec_summary);

            // Step 5: Draft each section
            $this->log_trace($runid, 'synthesis', 'Drafting sections');
            $sections = [];
            $section_count = 0;

            foreach ($nb_mapping as $nb_code => $section_title) {
                $nb_record = $this->get_or($nb_data, $nb_code, null);

                if (!$nb_record || $this->is_placeholder_nb($nb_record)) {
                    $this->log_trace($runid, 'synthesis', "Skipping placeholder: {$nb_code}");
                    continue;
                }

                // Draft section content
                $section_content = $this->draft_section_for_nb(
                    $nb_code,
                    $nb_record,
                    $section_title,
                    $metadata,
                    $citation_mgr,
                    $patterns,
                    $exec_inputs
                );

                // Apply voice enforcement and artifact removal
                if (!empty($section_content)) {
                    $section_content = $this->apply_voice_to_text($section_content);
                    $section_content = $this->remove_voice_artifacts($section_content);

                    // M3 Task 3.2: Generate formatted HTML for section
                    $formatted_html = null;
                    try {
                        $this->log_trace($runid, 'formatting', "[M3] Attempting to format section {$nb_code}: {$section_title}");

                        $formatted_html = $this->generate_formatted_section(
                            $nb_code,
                            $section_content,
                            [
                                'source_company_name' => isset($metadata['source_company']['name'])
                                    ? $metadata['source_company']['name']
                                    : 'Source Company',
                                'target_company_name' => isset($metadata['target_company']['name'])
                                    ? $metadata['target_company']['name']
                                    : 'Target Company',
                                'section_title' => $section_title
                            ],
                            $runid
                        );

                        if ($formatted_html) {
                            $this->log_trace($runid, 'formatting', "[M3] ‚úì Section {$nb_code} formatted successfully (" . strlen($formatted_html) . " chars)");
                        } else {
                            $this->log_trace($runid, 'formatting', "[M3] Section {$nb_code} formatting returned null, using plain fallback");
                        }
                    } catch (\Exception $e) {
                        $this->log_trace($runid, 'formatting', "[M3] Section {$nb_code} formatting failed: " . $e->getMessage());
                        $formatted_html = null;
                    }

                    $sections[$nb_code] = [
                        'title' => $section_title,
                        'content' => $section_content,         // Plain text (fallback)
                        'formatted_html' => $formatted_html,   // Structured HTML (M3)
                        'word_count' => str_word_count($section_content)
                    ];

                    $section_count++;
                }
            }

            $this->log_trace($runid, 'synthesis', "Generated {$section_count} sections");

            // M2.1: Generate structured executive summary from completed sections
            $this->log_trace($runid, 'synthesis', '[M2.1] Generating structured executive summary');
            $enhanced_exec_summary = $this->synthesis_engine->generate_executive_summary(
                $sections,
                $metadata,
                $runid
            );

            // M2.1: Additional cleanup for both fresh and cached summaries (catch-all)
            if ($enhanced_exec_summary) {
                $enhanced_exec_summary = str_replace('<p>.</p>', '', $enhanced_exec_summary);
                $enhanced_exec_summary = preg_replace('/<p[^>]*>\s*\.\s*<\/p>/i', '', $enhanced_exec_summary);
                $enhanced_exec_summary = preg_replace('/>\s*\.\s*$/s', '', $enhanced_exec_summary);
                $enhanced_exec_summary = trim($enhanced_exec_summary);
                $this->log_trace($runid, 'synthesis', '[M2.1] Applied catch-all cleanup to executive summary');
            }

            // Use structured summary if successful (check for error message)
            if ($enhanced_exec_summary && $enhanced_exec_summary !== '<p>Executive summary could not be generated at this time.</p>') {
                $exec_summary = $enhanced_exec_summary;
                $this->log_trace($runid, 'synthesis', '[M2.1] Using structured HTML executive summary');
            } else {
                $this->log_trace($runid, 'synthesis', '[M2.1] Structured summary failed, using template-based fallback');
            }

            // Step 6: Assemble Markdown report
            $markdown = $this->assemble_markdown_report(
                $metadata,
                $exec_summary,
                $sections,
                $citation_mgr
            );

            $payload_size = strlen($markdown);
            $citation_count = count($citation_mgr->get_all_citations());

            // Step 7: Calculate QA scores
            $qa_scores = $this->calculate_qa_scores(
                $sections,
                ['nb' => $nb_data],
                1.0,
                1.0
            );

            // Step 7.1: Extract all unique citations from canonical nb_data (moved up for QA metrics)
            $all_citations = [];
            $citation_map = [];
            $citation_id = 1;

            if (!empty($nb_data)) {
                foreach ($nb_data as $nb_code => $nb_content) {
                    $nb_citations = $nb_content['citations'] ?? [];
                    foreach ($nb_citations as $citation) {
                        $url = is_array($citation) ? ($citation['url'] ?? '') : $citation;
                        if ($url && !isset($citation_map[$url])) {
                            $citation_map[$url] = true;
                            $all_citations[] = [
                                'id' => $citation_id,
                                'url' => $url,
                                'title' => is_array($citation) ? ($citation['title'] ?? 'Source ' . $citation_id) : 'Source ' . $citation_id
                            ];
                            $citation_id++;
                        }
                    }
                }
            }

            // Step 7.2: Calculate basic QA metrics
            // Prepare all sections text for analysis
            $all_sections_text = '';
            foreach ($sections as $section) {
                $all_sections_text .= $section['content'] . "\n\n";
            }

            // Calculate individual scores
            $evidence_score = $this->calculate_evidence_strength_score($all_sections_text, $all_citations);
            // Extract just the content strings from sections array
            $section_contents = array_map(function($section) {
                return $section['content'];
            }, $sections);
            $completeness_score = $this->calculate_completeness_score($section_contents);
            $readability_score = $this->calculate_readability_score($all_sections_text);
            $citation_validation = $this->validate_citation_density(['nb_data' => $nb_data]);

            // Initialize telemetry logger for QA metrics
            $telemetry = new \local_customerintel\services\telemetry_logger();

            // Log QA metrics to telemetry
            $telemetry->log_metric($runid, 'qa_evidence_strength', $evidence_score);
            $telemetry->log_metric($runid, 'qa_completeness', $completeness_score);
            $telemetry->log_metric($runid, 'qa_readability', $readability_score);
            $telemetry->log_metric($runid, 'qa_citation_density_avg', $citation_validation['average']);
            $telemetry->log_metric($runid, 'qa_citation_density_total', $citation_validation['total']);

            // Calculate overall weighted score
            $overall_qa = (
                $evidence_score * 0.30 +
                $completeness_score * 0.25 +
                $readability_score * 0.25 +
                ($citation_validation['meets_target'] ? 0.20 : 0.10)
            );

            $telemetry->log_metric($runid, 'qa_overall_score', round($overall_qa, 2));

            error_log("[QA-SCORES] Run $runid | Evidence: $evidence_score | Complete: $completeness_score | Read: $readability_score | Overall: $overall_qa");
            error_log("[SYNTHESIS-COMPOSER] Extracted " . count($all_citations) . " unique citations from canonical nb_data");

            // Count actual citation references in the markdown text
            // This matches what's displayed to the user (e.g., [1], [2], [3], etc.)
            preg_match_all('/\[(\d+)\]/', $markdown, $citation_matches);
            $unique_citations = array_unique($citation_matches[1]);
            $citation_count = count($unique_citations);

            error_log("[SYNTHESIS-COMPOSER] Citations in nb_data: " . count($all_citations));
            error_log("[SYNTHESIS-COMPOSER] Citations referenced in markdown: {$citation_count}");
            error_log("[SYNTHESIS-COMPOSER] Unreferenced citations: " . (count($all_citations) - $citation_count));

            // M1 Task 3: Enhance metadata with complete provenance and cache validation
            $metadata = $this->enhance_metadata_with_m1t3_fields($metadata, $runid, $section_count);

            // Step 8: Save as synthesis_final_bundle artifact
            $bundle_data = [
                'final_report' => $markdown,
                'executive_summary' => $exec_summary,  // M2 Phase 2: Store enhanced executive summary
                'sections' => $sections,               // M3 Task 3.3: Store sections with formatted_html
                'qa_scores' => $qa_scores,
                'section_count' => $section_count,
                'citation_count' => $citation_count,
                'citations' => $all_citations,
                'metadata' => $metadata,
                'generation_timestamp' => time()
            ];

            $artifact_id = $DB->insert_record('local_ci_artifact', [
                'runid' => $runid,
                'artifacttype' => 'synthesis_final_bundle',
                'phase' => 'synthesis',
                'jsondata' => json_encode($bundle_data),
                'payload_size' => $payload_size,
                'timecreated' => time()
            ]);

            // Step 9: Log telemetry
            $this->log_trace($runid, 'synthesis', 'Synthesis composer completed', [
                'artifact_id' => $artifact_id,
                'sections' => $section_count,
                'citations' => $citation_count,
                'payload_size' => $payload_size,
                'qa_score' => $this->get_or($qa_scores, 'overall', 0)
            ]);

            $this->end_phase_timer($runid, 'synthesis_composition', 'success',
                "Generated {$section_count} sections with {$citation_count} citations", []);

            // M2 Task 0.1: Set status to 'completed' after synthesis finishes
            $DB->update_record('local_ci_run', (object)[
                'id' => $runid,
                'status' => 'completed',
                'timecompleted' => time(),
                'timemodified' => time()
            ]);

            $this->log_trace($runid, 'synthesis', 'Synthesis complete - status set to completed', [
                'sections' => $section_count,
                'citations' => $citation_count
            ]);

            return true;

        } catch (\Exception $e) {
            $this->end_phase_timer($runid, 'synthesis_composition', 'error',
                $e->getMessage(), ['exception' => get_class($e)]);

            $this->log_trace($runid, 'synthesis', 'Synthesis composer failed', [
                'error' => $e->getMessage(),
                'trace' => $e->getTraceAsString()
            ]);

            // Log to diagnostics
            $DB->insert_record('local_ci_diagnostics', [
                'runid' => $runid,
                'metric' => 'synthesis_composition_error',
                'severity' => 'error',
                'message' => $e->getMessage(),
                'timecreated' => time()
            ]);

            return false;
        }
    }

    /**
     * Draft section content for a Neural Block
     *
     * @param string $nb_code NB code (e.g., 'NB-1')
     * @param array $nb_record NB record data
     * @param string $section_title Section title
     * @param array $metadata Run metadata
     * @param CitationManager $citation_mgr Citation manager
     * @param array $patterns Detected patterns
     * @param array $inputs Executive inputs
     * @return string Section content (AI-generated narrative)
     */
    private function draft_section_for_nb($nb_code, $nb_record, $section_title, $metadata, $citation_mgr, $patterns, $inputs) {

        // ALWAYS use AI synthesis for consistent Gold Standard quality
        // No more special cases - all sections get professional AI-generated narrative
        return $this->synthesize_section_from_nb($nb_record, $section_title, $metadata, $citation_mgr);
    }

    /**
     * Synthesize section narrative from NB data using OpenAI
     *
     * @param array $nb_record NB record with data, citations, status
     * @param string $section_title Section title for context
     * @param array $metadata Run metadata
     * @param CitationManager $citation_mgr Citation manager
     * @return string Section narrative
     */
    private function synthesize_section_from_nb($nb_record, $section_title, $metadata, $citation_mgr) {

        $runid = $metadata['runid'] ?? 0;

        try {
            // Step 1: Get Gold Standard example for this section
            $gold_standard_example = $this->get_gold_standard_example($section_title);

            if (empty($gold_standard_example)) {
                error_log("[SYNTHESIS-AI] No Gold Standard example for {$section_title}");
            }

            // Step 2: Build synthesis prompt
            $prompt = $this->build_synthesis_prompt(
                $section_title,
                $nb_record,
                $metadata,
                $gold_standard_example
            );

            // Step 3: Call OpenAI to generate narrative
            $this->log_trace($runid, 'synthesis', "Generating AI narrative for: {$section_title}");
            $start_time = microtime(true);

            $narrative = $this->call_openai_for_synthesis($prompt, 1500);

            // LAYER 2: POST-PROCESSING CLEANUP (after OpenAI response)
            $before_count = substr_count($narrative, '...');
            error_log("[ELLIPSIS-DEBUG] Section: $section_title | Before: $before_count triple-dots");

            // Apply robust 3-layer ellipses cleaning
            $narrative = $this->clean_ellipses_and_truncations($narrative);

            $after_count = substr_count($narrative, '...');
            error_log("[ELLIPSIS-DEBUG] Section: $section_title | After: $after_count triple-dots | Removed: " . ($before_count - $after_count));

            $duration = round((microtime(true) - $start_time) * 1000);

            // Step 4: Validate generated content
            if (empty($narrative)) {
                error_log("[SYNTHESIS-AI] Empty narrative generated for {$section_title}");
                throw new \Exception("Empty narrative generated");
            }

            if (strlen($narrative) < 100) {
                error_log("[SYNTHESIS-AI] Generated narrative too short for {$section_title} (length: " . strlen($narrative) . ")");
                throw new \Exception("Generated narrative too short");
            }

            // Check for incomplete sentences (ellipses)
            if (substr_count($narrative, '...') > 2) {
                error_log("[SYNTHESIS-AI] Generated narrative has too many ellipses for {$section_title}");
                // Don't throw - just log warning
            }

            // Step 5: Add citations to citation manager
            $citations = $this->as_array($this->get_or($nb_record, 'citations', []));
            $citations_added = 0;

            foreach ($citations as $citation) {
                $citation_url = '';
                $citation_title = 'Source';

                // Handle different citation formats
                if (is_string($citation)) {
                    $citation_url = $citation;
                } elseif (is_array($citation)) {
                    $citation_url = $citation['url'] ?? '';
                    $citation_title = $citation['title'] ?? 'Source';

                    // Fallback: if url not found, try first element
                    if (empty($citation_url) && isset($citation[0])) {
                        $citation_url = $citation[0];
                    }
                }

                // Only add if we have a valid URL string
                if (!empty($citation_url) && is_string($citation_url)) {
                    try {
                        $citation_mgr->add_citation([
                            'url' => trim($citation_url),
                            'title' => $citation_title
                        ]);
                        $citations_added++;
                    } catch (\Exception $e) {
                        error_log("[SYNTHESIS-AI] Failed to add citation: " . $e->getMessage());
                        // Continue with other citations
                    }
                }
            }

            $this->log_trace($runid, 'synthesis', "AI narrative generated for: {$section_title}", [
                'length' => strlen($narrative),
                'citations_added' => $citations_added,
                'duration_ms' => $duration
            ]);

            error_log("[SYNTHESIS-AI] ‚úì {$section_title} completed in {$duration}ms, {$citations_added} citations");

            return $narrative;

        } catch (\Exception $e) {
            error_log("[SYNTHESIS-AI] Failed to generate narrative for {$section_title}: " . $e->getMessage());

            // Fallback to enriched template
            $this->log_trace($runid, 'synthesis', "Using fallback for {$section_title} due to AI error");

            return $this->generate_enriched_fallback($section_title, $nb_record['nbcode'] ?? '', $metadata);
        }
    }

    /**
     * Call OpenAI API for synthesis
     *
     * @param string $prompt Synthesis prompt
     * @param int $max_tokens Maximum tokens to generate
     * @return string Generated narrative
     */
    private function call_openai_for_synthesis($prompt, $max_tokens = 1500) {
        return $this->synthesis_engine->call_openai_for_synthesis($prompt, $max_tokens);
    }

    /**
     * Build synthesis prompt for AI
     *
     * @param string $section_title Section title
     * @param array $nb_record NB record data
     * @param array $metadata Run metadata
     * @param string $gold_standard_example Gold standard example
     * @return string Synthesis prompt
     */
    private function build_synthesis_prompt($section_title, $nb_record, $metadata, $gold_standard_example) {
        return $this->synthesis_engine->build_synthesis_prompt($section_title, $nb_record, $metadata, $gold_standard_example);
    }

    /**
     * Get Gold Standard example for section
     *
     * @param string $section_title Section title
     * @return string Gold standard example
     */
    private function get_gold_standard_example($section_title) {
        return $this->synthesis_engine->get_gold_standard_example($section_title);
    }

    /**
     * Apply voice enforcement to text
     *
     * @param string $text Input text
     * @return string Voice-enforced text
     */
    private function apply_voice_to_text($text) {
        return $this->synthesis_engine->apply_voice_to_text($text);
    }

    /**
     * Remove voice artifacts from text
     *
     * @param string $text Input text
     * @return string Cleaned text
     */
    private function remove_voice_artifacts($text) {
        return $this->synthesis_engine->remove_voice_artifacts($text);
    }

    /**
     * Clean ellipses and truncations from text
     *
     * @param string $text Input text
     * @return string Cleaned text
     */
    private function clean_ellipses_and_truncations($text) {
        return $this->synthesis_engine->clean_ellipses_and_truncations($text);
    }

    /**
     * Assemble markdown report
     *
     * @param array $metadata Run metadata
     * @param string $exec_summary Executive summary
     * @param array $sections Report sections
     * @param CitationManager $citation_mgr Citation manager
     * @return string Markdown report
     */
    private function assemble_markdown_report($metadata, $exec_summary, $sections, $citation_mgr) {
        return $this->synthesis_engine->assemble_markdown_report($metadata, $exec_summary, $sections, $citation_mgr);
    }

    /**
     * Calculate QA scores
     *
     * @param array $sections Report sections
     * @param array $inputs Input data
     * @param float $pattern_weight Pattern weight
     * @param float $coherence_weight Coherence weight
     * @return array QA scores
     */
    private function calculate_qa_scores($sections, $inputs, $pattern_weight, $coherence_weight) {
        return $this->synthesis_engine->calculate_qa_scores($sections, $inputs, $pattern_weight, $coherence_weight);
    }

    /**
     * Calculate evidence strength score
     *
     * @param string $text Report text
     * @param array $citations Citations
     * @return float Evidence score
     */
    private function calculate_evidence_strength_score($text, $citations) {
        return $this->synthesis_engine->calculate_evidence_strength_score($text, $citations);
    }

    /**
     * Calculate completeness score
     *
     * @param array $section_contents Section contents
     * @return float Completeness score
     */
    private function calculate_completeness_score($section_contents) {
        return $this->synthesis_engine->calculate_completeness_score($section_contents);
    }

    /**
     * Calculate readability score
     *
     * @param string $text Report text
     * @return float Readability score
     */
    private function calculate_readability_score($text) {
        return $this->synthesis_engine->calculate_readability_score($text);
    }

    /**
     * Validate citation density
     *
     * @param array $data Input data
     * @return array Citation validation results
     */
    private function validate_citation_density($data) {
        return $this->synthesis_engine->validate_citation_density($data);
    }

    /**
     * Enhance metadata with M1T3 fields
     *
     * @param array $metadata Current metadata
     * @param int $runid Run ID
     * @param int $section_count Section count
     * @return array Enhanced metadata
     */
    private function enhance_metadata_with_m1t3_fields($metadata, $runid, $section_count) {
        return $this->synthesis_engine->enhance_metadata_with_m1t3_fields($metadata, $runid, $section_count);
    }

    /**
     * Generate enriched fallback content
     *
     * @param string $section_title Section title
     * @param string $nb_code NB code
     * @param array $metadata Run metadata
     * @return string Fallback content
     */
    private function generate_enriched_fallback($section_title, $nb_code, $metadata) {
        return $this->synthesis_engine->generate_enriched_fallback($section_title, $nb_code, $metadata);
    }

    /**
     * Detect patterns in inputs
     *
     * @param array $inputs Input data
     * @return array Detected patterns
     */
    private function detect_patterns($inputs) {
        return $this->synthesis_engine->detect_patterns($inputs);
    }

    /**
     * Draft executive insight
     *
     * @param array $inputs Input data
     * @param array $patterns Detected patterns
     * @param CitationManager $citation_mgr Citation manager
     * @return array Executive insight result
     */
    private function draft_executive_insight($inputs, $patterns, $citation_mgr) {
        return $this->synthesis_engine->draft_executive_insight($inputs, $patterns, $citation_mgr);
    }

    /**
     * Log trace event
     *
     * @param int $runid Run ID
     * @param string $phase Phase name
     * @param string $message Trace message
     * @param array $context Additional context
     */
    private function log_trace($runid, $phase, $message, $context = []) {
        $this->synthesis_engine->log_trace($runid, $phase, $message, $context);
    }

    /**
     * Start phase timer
     *
     * @param int $runid Run ID
     * @param string $phase Phase name
     */
    private function start_phase_timer($runid, $phase) {
        $this->synthesis_engine->start_phase_timer($runid, $phase);
    }

    /**
     * End phase timer
     *
     * @param int $runid Run ID
     * @param string $phase Phase name
     * @param string $status Status (success/error)
     * @param string $message Status message
     * @param array $context Additional context
     */
    private function end_phase_timer($runid, $phase, $status, $message, $context) {
        $this->synthesis_engine->end_phase_timer($runid, $phase, $status, $message, $context);
    }

    /**
     * Utility: Ensure value is array
     *
     * @param mixed $v Value to convert
     * @return array Array value
     */
    private function as_array($v): array {
        return $this->synthesis_engine->as_array($v);
    }

    /**
     * Utility: Get value or default
     *
     * @param array $a Array
     * @param string $key Key to get
     * @param mixed $default Default value
     * @return mixed Value or default
     */
    private function get_or($a, string $key, $default = null) {
        return $this->synthesis_engine->get_or($a, $key, $default);
    }

    /**
     * Utility: Check if NB is placeholder
     *
     * @param array $nb_data NB data
     * @return bool True if placeholder
     */
    private function is_placeholder_nb(array $nb_data): bool {
        return $this->synthesis_engine->is_placeholder_nb($nb_data);
    }

    /**
     * M3.5: Generate CVS-style strategic opportunity brief for a single NB section
     *
     * Transforms raw section content into CVS-style 7-part opportunity brief using OpenAI GPT-4o.
     *
     * 7-part structure:
     * 1. What Is Happening
     * 2. Why This Matters Now
     * 3. Current Performance Gap (with metrics)
     * 4. What the Target Company Needs
     * 5. What the Source Company Offers
     * 6. Timeline & Urgency
     * 7. Executive Accountability
     *
     * @param string $nb_code NB code (NB1-NB15)
     * @param string $content Raw section content (plain text)
     * @param array $metadata Contains source_company_name, target_company_name, section_title
     * @param int $runid For logging
     * @return string|null Formatted CVS-style HTML or null if formatting fails
     */
    private function generate_formatted_section($nb_code, $content, $metadata, $runid) {
        $this->log_trace($runid, 'synthesis', "[M3.5] Starting CVS-style section formatting for {$nb_code}");

        // Extract company names and section title
        $source_company_name = $metadata['source_company_name'] ?? 'Source Company';
        $target_company_name = $metadata['target_company_name'] ?? 'Target Company';
        $section_title = $metadata['section_title'] ?? 'Section';

        // INSIGHT CLUSTERS FORMAT: All 15 sections use custom Insight Clusters prompts
        // Each section has a tailored prompt in the switch statement below
        $this->log_trace($runid, 'synthesis', "[Insight Clusters] Generating {$nb_code} with Insight Clusters format");

        // Base context (shared across all sections)
        $base_context = "You are an executive intelligence analyst producing strategic insight briefs for a B2B client.

CONTEXT:
- Source Company (reader employer): {$source_company_name}
- Target Company (the subject of the report): {$target_company_name}
- Section: {$section_title} ({$nb_code})
- Relationship Type: Prospective alliance or strategic partnership
- Audience: Senior executives at the source company
- Purpose: Identify strategic opportunities, risks, or insight areas to advance partnership and value creation
- Tone: Authoritative, analytical, evidence-backed, executive-ready

DATA AVAILABLE FOR THIS SECTION:
{$content}";

        // Section-specific Insight Clusters prompts (each section has complete formatting instructions)
        switch ($nb_code) {
            case 'NB2':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use revenue figures, R&D efficiency, operating margins
- Instead of repeating <10%: Use specific product sales, ROI projections, cost savings
- Fresh evidence: Partnership financial value, budget cycles, CFO priorities

TASK: Generate Financial Performance section analyzing {$target_company_name}'s financial health and market dynamics.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Revenue exposure and market dynamics
- Cluster 2: Operating performance and R&D efficiency
- Cluster 3: Partnership financial value and ROI
- Cluster 4: Budget cycles and financial decision authority

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data

FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS (provide new specific data):
- Specific numbers: \"J&J operates 275 distribution centers across 60 countries\"
- Specific dates: \"Cabotegravir approved in EU March 2021\"
- Specific timelines: \"Partnership could reach 15M additional patients by 2027\"
- Competitive benchmarks: \"Merck's operating margin improved 8% post-Ridgeback deal\"
- Executive mandates: \"CFO Jessica Moore tied 2026 bonus to partnership ROI metrics\"
- Financial specifics: \"HIV treatment R&D budget increased 22% in FY2024\"

‚ùå BAD FACTS (repeat the paragraph):
- \"Operating margin is under pressure\" ‚Üê Already stated in paragraph
- \"R&D investment needs are mounting\" ‚Üê Already stated
- \"Partnership efficiency gains achievable\" ‚Üê Generic restatement

CRITICAL THINKING:
Ask: \"If I removed this bullet, would the reader lose NEW information or just see the same info again?\"
If \"same info again\" ‚Üí DON'T include that bullet.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC INSIGHTS:
- \"Operating margin declined from 42% to 38% over 3 years despite 5% revenue growth\"
- \"R&D spend at 18% of revenue vs industry benchmark of 22%\"
- \"CFO accountability tied to Q1 2026 budget approval cycle\"
- \"ViiV partnership could reduce cost per HIV patient by \$2,400 annually\"

‚ùå GENERIC INSIGHTS (never acceptable):
- \"Operating performance shows challenges\" ‚Üê What challenges? How big?
- \"R&D investment is important\" ‚Üê How much? Compared to what?
- \"Financial alignment creates value\" ‚Üê How much value?

QUALITY TEST:
Ask: \"Could this insight apply to ANY pharmaceutical partnership?\"
- If YES ‚Üí Too generic, add specifics
- If NO ‚Üí Good, it's specific to this situation

STRATEGIC vs PROCESS-FOCUSED:

‚ùå PROCESS-FOCUSED (avoid):
- \"Establishing budget alignment is essential\"
- \"Financial governance timelines are critical\"

‚úÖ STRATEGIC INSIGHTS (use):
- \"Q1 2026 budget cycle creates 90-day decision window before fiscal lock\"
- \"CFO Jessica Moore holds veto authority over partnerships exceeding \$100M\"

RULE: Every bold insight sentence must identify a specific gap, risk, or opportunity AND the quantified impact.


CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE CLUSTER:

<p><b>Operating Margin Pressure Mounting Amid R&D Investment Needs</b></p>

<p>Johnson & Johnson maintains a 38% operating margin despite diversified revenue streams [1], but faces mounting pressure to sustain profitability while increasing R&D investment in specialty medicines. ViiV Healthcare demonstrates a proven model with 38% operating margins maintained despite a 22% R&D increase [2], suggesting partnership efficiency gains are achievable. The HIV treatment market projected 6.5% CAGR through 2027 [3] creates revenue opportunity that could offset margin pressure if captured effectively through strategic collaboration.</p>

<ul>
<li>J&J operating margin declined from 42% (2021) to 38% (2024) despite 5% revenue growth [1]</li>
<li>R&D spend at 18% of revenue vs ViiV's 22% and industry benchmark of 21% [2]</li>
<li>ViiV's HIV portfolio generates \$4.2B annually with 32% market share [3]</li>
<li>Partnership ROI modeling shows \$500M revenue potential by 2028 with 45% margin</li>
<li>CFO Jessica Moore and VP Finance Dan Miller hold joint P&L accountability for HIV portfolio</li>
</ul>


CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Financial Performance section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Market share comparisons (Company Overview section)
   - Distribution infrastructure (Company Overview section)
   - Executive mandates (Leadership section)
   - Regulatory deadlines (Operational Risks section)
   - Patient projections (Growth Opportunities section)

ALLOWED METRICS for THIS section:
   - Specific revenue opportunities with dollar amounts
   - R&D spend metrics and efficiency ratios
   - ROI projections and financial synergies
   - Operating margins and cost structures

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to financial performance.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: Financial value proposition, cost synergies, ROI potential

YOU MAY:
- Discuss how source company capabilities address target's financial performance needs
- Mention partnership implications specific to financial performance
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique financial performance insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB5':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use pipeline delays, development timelines, IND submissions
- Instead of repeating <10%: Use capability gaps, infrastructure challenges
- Fresh evidence: Regulatory milestones, supply chain issues, R&D accountability

TASK: Generate Operational Risks section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Pipeline challenges and development timelines
- Cluster 2: Clinical infrastructure and capability gaps
- Cluster 3: Partnership acceleration opportunities
- Cluster 4: Regulatory milestones and R&D accountability

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data

FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS:
- \"Clinical trial completion time 18 months vs industry benchmark 12 months\"
- \"Manufacturing facility utilization at 67% vs optimal 85%\"
- \"FDA approval timeline for lead compound delayed by 9 months to Q4 2026\"
- \"Supply chain lead times average 45 days vs competitor 30 days\"

‚ùå BAD FACTS:
- \"Pipeline challenges exist\" ‚Üê Already stated
- \"Infrastructure gaps need addressing\" ‚Üê Already stated

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED.

‚úÖ SPECIFIC INSIGHTS:
- \"IND filings delayed 9 months; only 2 of 7 planned INDs submitted in 2024\"
- \"Clinical trial enrollment 23% below target vs Merck's 105% enrollment rate\"
- \"R&D Chief mandated pipeline acceleration in Aug 2024 board meeting\"

‚ùå GENERIC INSIGHTS (never acceptable):
- \"Pipeline challenges exist\" ‚Üê What challenges? How big?
- \"Infrastructure capabilities need improvement\" ‚Üê Which capabilities?

QUALITY TEST: Ask \"Could this apply to ANY pharma company?\" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps, risks, impacts) not HOW to manage it.


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Operational Risks section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Market share comparisons (Company Overview section)
   - Revenue opportunities (Financial section)
   - Distribution infrastructure (Company Overview section)
   - Patient projections (Growth Opportunities section)

ALLOWED METRICS for THIS section:
   - Specific revenue risks with dollar amounts
   - Regulatory and payer deadlines
   - Pipeline delays and development timelines
   - Infrastructure gaps and capability weaknesses

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to operational risks.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: How partnership mitigates operational risks

YOU MAY:
- Discuss how source company capabilities address target's operational risks needs
- Mention partnership implications specific to operational risks
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique operational risks insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB7':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use competitive rankings, market growth rates
- Instead of repeating <10%: Use specific product positioning, therapeutic area share
- Fresh evidence: Competitive dynamics, market threats, partnership positioning

TASK: Generate Market & Competitive Positioning section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Market position and competitive dynamics
- Cluster 2: Strategic execution gaps and market threats
- Cluster 3: Partnership positioning advantages
- Cluster 4: Market strategy timeline and leadership

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Market & Competitive Positioning section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Revenue opportunities/risks (Financial/Operational sections)
   - Distribution infrastructure (Company Overview section)
   - Executive mandates (Leadership section)
   - Regulatory deadlines (Operational Risks section)

ALLOWED METRICS for THIS section:
   - Market size projections with dollar amounts
   - Competitive benchmarks vs named competitors
   - Market share trends and positioning
   - Differentiation factors

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to market & competitive positioning.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: How partnership improves competitive position

YOU MAY:
- Discuss how source company capabilities address target's market & competitive positioning needs
- Mention partnership implications specific to market & competitive positioning
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique market & competitive positioning insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB1':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use portfolio composition, therapeutic area rankings
- Instead of repeating <10%: Use specific drug performance, geographic reach
- Fresh evidence: Market positioning data, partnership requirements, decision authority

TASK: Generate Company Overview section analyzing {$target_company_name}'s strategic positioning and portfolio.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Portfolio positioning and market presence
- Cluster 2: Strategic gaps and competitive differentiation
- Cluster 3: Partnership requirements and value alignment
- Cluster 4: Decision authority and engagement timeline

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>Portfolio Concentration Risk in Non-HIV Therapeutic Areas</b></p>

<p>Johnson & Johnson's \$52.6B pharmaceutical portfolio demonstrates strong presence in oncology and vaccines, where it commands 23% global market share in immunology [1]. However, the company faces a significant competitive differentiation gap in specialized HIV treatment, with market share under 10% compared to ViiV Healthcare's 32% share in the global HIV market [2]. This portfolio concentration creates strategic risk as HIV treatment market is projected to grow at 6.5% CAGR through 2027, representing a \$3.2B addressable opportunity that J&J is currently underserving [3].</p>

<ul>
<li>J&J generated \$52.6B in pharmaceutical revenue in 2024, ranked #6 globally [1]</li>
<li>Portfolio includes 8 blockbuster drugs with \$1B+ annual revenue each</li>
<li>Market leader in immunology with 23% global market share [1]</li>
<li>HIV market share under 10% vs ViiV's 32% global share [2]</li>
<li>HIV treatment market projected 6.5% CAGR through 2027 [3]</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence Here</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Company Overview section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Specific revenue opportunity projections (Financial section)
   - Specific revenue risk figures (Operational Risks section)
   - Patient reach projections (Growth Opportunities section)
   - CEO mandates or board directives (Leadership section)
   - Regulatory/payer deadlines (Operational Risks section)

ALLOWED METRICS for THIS section:
   - Market share comparisons (source vs target vs competitors)
   - Portfolio composition (therapeutic areas, revenue mix)
   - Distribution infrastructure (number of centers, geographic reach)
   - General competitive positioning data

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to company overview.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: How source company capabilities fit with target portfolio gaps

YOU MAY:
- Discuss how source company capabilities address target's company overview needs
- Mention partnership implications specific to company overview
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique company overview insights.



CITATION DISTRIBUTION REQUIREMENTS - CRITICAL:

You MUST use citations from ALL 15 Neural Blocks across the full range.

REQUIRED DISTRIBUTION:
- Early range [1-85] (NB1-5): Include at least 2 citations
- Middle range [86-170] (NB6-10): Include at least 2 citations
- Late range [171-250+] (NB11-15): Include at least 2 citations

ENFORCEMENT:
- MUST NOT have citation gaps larger than 50 consecutive numbers
- A section using only citations [1-50] while ignoring [150-250] will FAIL quality check
- Track which citations you have used and deliberately seek unused ones

‚úÖ GOOD: [12, 45, 89, 134, 178, 221] - spans full range
‚ùå BAD: [1, 3, 5, 7, 9, 11] - only uses early citations

Why this matters:
- Intelligence data contains 250+ citations from diverse sources
- Using only early citations ignores 80% of available evidence
- Complete analysis requires drawing from ALL Neural Blocks



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB3':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use executive mandates, R&D investment figures
- Instead of repeating <10%: Use governance structure, decision timelines
- Fresh evidence: Board priorities, executive accountability, leadership alignment

TASK: Generate Leadership & Governance section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Board priorities and executive mandates
- Cluster 2: Decision-making challenges and governance gaps
- Cluster 3: Leadership alignment opportunities
- Cluster 4: Governance timeline and executive accountability

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Leadership & Governance section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Market share comparisons (Company Overview section)
   - Revenue opportunities/risks (Financial/Operational sections)
   - Patient projections (Growth Opportunities section)
   - Regulatory deadlines (Operational Risks section)

ALLOWED METRICS for THIS section:
   - CEO and executive mandates
   - Board directives and governance structure
   - Decision-making authority and processes
   - Executive backgrounds and priorities

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to leadership & governance.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: Decision-making alignment, executive sponsorship

YOU MAY:
- Discuss how source company capabilities address target's leadership & governance needs
- Mention partnership implications specific to leadership & governance
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique leadership & governance insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB4':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use R&D output, patent portfolio, innovation metrics
- Instead of repeating <10%: Use specific initiative outcomes, program KPIs
- Fresh evidence: Strategic priorities, execution gaps, initiative enablement

TASK: Generate Strategic Initiatives section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Current strategic focus and investment priorities
- Cluster 2: Execution gaps and program performance
- Cluster 3: Initiative enablement through partnership
- Cluster 4: Program milestones and leadership ownership

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Strategic Initiatives section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Market share comparisons (Company Overview section)
   - Revenue opportunities/risks (Financial/Operational sections)
   - Distribution infrastructure (Company Overview section)
   - Executive mandates (Leadership section)

ALLOWED METRICS for THIS section:
   - Current strategic programs and initiatives
   - M&A activity and investment priorities
   - Geographic and therapeutic expansion plans
   - Resource allocation across initiatives

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to strategic initiatives.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: How partnership enables strategic initiatives

YOU MAY:
- Discuss how source company capabilities address target's strategic initiatives needs
- Mention partnership implications specific to strategic initiatives
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique strategic initiatives insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB6':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use digital investment figures, platform capabilities
- Instead of repeating <10%: Use technology gaps, AI/ML adoption metrics
- Fresh evidence: Digital roadmap, tech leadership, platform partnerships

TASK: Generate Technology & Digital section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Digital transformation priorities and investment
- Cluster 2: Technology capability gaps and innovation lag
- Cluster 3: Platform synergies and digital partnership value
- Cluster 4: Technology roadmap and digital leadership

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Technology & Digital section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Market share comparisons (Company Overview section)
   - Revenue opportunities/risks (Financial/Operational sections)
   - Distribution infrastructure (Company Overview section)
   - Executive mandates (Leadership section)

ALLOWED METRICS for THIS section:
   - Digital investment figures and technology spend
   - Platform capabilities and gaps
   - Implementation timelines and tech roadmap
   - Data analytics and AI capabilities

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to technology & digital.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: Technology collaboration opportunities

YOU MAY:
- Discuss how source company capabilities address target's technology & digital needs
- Mention partnership implications specific to technology & digital
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique technology & digital insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB8':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use employee count, division revenue split
- Instead of repeating <10%: Use organizational structure details, culture metrics
- Fresh evidence: Integration considerations, change management history

TASK: Generate Organizational Structure & Culture section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Organizational design and structural dynamics
- Cluster 2: Cultural alignment challenges and performance impact
- Cluster 3: Partnership cultural fit and integration
- Cluster 4: Organizational timeline and change leadership

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Organizational Structure & Culture section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Market share comparisons (Company Overview section)
   - Revenue opportunities/risks (Financial/Operational sections)
   - Distribution infrastructure (Company Overview section)
   - Executive mandates (Leadership section)
   - Regulatory deadlines (Operational Risks section)

ALLOWED METRICS for THIS section:
   - Organizational structure and reporting lines
   - Culture attributes and values
   - Change management capabilities
   - Integration experience and challenges

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to organizational structure & culture.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: Cultural fit and integration planning

YOU MAY:
- Discuss how source company capabilities address target's organizational structure & culture needs
- Mention partnership implications specific to organizational structure & culture
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique organizational structure & culture insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB9':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use partnership count, stakeholder engagement metrics
- Instead of repeating <10%: Use advocacy group relationships, investor details
- Fresh evidence: Partnership ecosystem, external relationships, collaboration history

TASK: Generate Stakeholders & Partnerships section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Stakeholder landscape and engagement
- Cluster 2: Partnership urgency drivers and gaps
- Cluster 3: Collaborative value and stakeholder alignment
- Cluster 4: Stakeholder timeline and partnership leadership

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Stakeholders & Partnerships section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Market share comparisons (Company Overview section)
   - Revenue opportunities/risks (Financial/Operational sections)
   - Distribution infrastructure (Company Overview section)
   - Executive mandates (Leadership section)
   - Regulatory deadlines (Operational Risks section)

ALLOWED METRICS for THIS section:
   - Existing partnership portfolio and performance
   - Stakeholder engagement metrics
   - Collaboration models and governance
   - Partner ecosystem strengths

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to stakeholders & partnerships.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: Partnership ecosystem fit

YOU MAY:
- Discuss how source company capabilities address target's stakeholders & partnerships needs
- Mention partnership implications specific to stakeholders & partnerships
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique stakeholders & partnerships insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB10':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use carbon reduction targets, ESG rankings
- Instead of repeating <10%: Use sustainability investment, governance scores
- Fresh evidence: ESG commitments, sustainability gaps, reporting timelines

TASK: Generate ESG Sustainability section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: ESG commitments and current performance
- Cluster 2: Sustainability gaps and pressure points
- Cluster 3: Partnership ESG value and impact acceleration
- Cluster 4: ESG reporting timeline and leadership accountability

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the ESG & Sustainability section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Market share comparisons (Company Overview section)
   - Revenue opportunities/risks (Financial/Operational sections)
   - Distribution infrastructure (Company Overview section)
   - Executive mandates (Leadership section)
   - Regulatory deadlines (Operational Risks section)

ALLOWED METRICS for THIS section:
   - ESG commitments and targets
   - Sustainability metrics and progress
   - Carbon and environmental targets
   - Social responsibility initiatives

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to esg & sustainability.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: ESG alignment and joint initiatives

YOU MAY:
- Discuss how source company capabilities address target's esg & sustainability needs
- Mention partnership implications specific to esg & sustainability
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique esg & sustainability insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB11':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use R&D spend, pipeline metrics, patent data
- Instead of repeating <10%: Use collaboration count, innovation output
- Fresh evidence: R&D pipeline, collaboration opportunities, innovation gaps

TASK: Generate Innovation & Collaboration section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Innovation strategy and portfolio focus
- Cluster 2: Collaboration gaps and partnership needs
- Cluster 3: Joint innovation opportunities and synergies
- Cluster 4: Innovation cycle timeline and R&D leadership

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Innovation & Collaboration section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Market share comparisons (Company Overview section)
   - Revenue opportunities/risks (Financial/Operational sections)
   - Distribution infrastructure (Company Overview section)
   - Executive mandates (Leadership section)
   - Regulatory deadlines (Operational Risks section)

ALLOWED METRICS for THIS section:
   - R&D pipeline composition and progress
   - Innovation investments and methods
   - Collaboration and licensing track record
   - Patent portfolio and IP strategy

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to innovation & collaboration.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: Joint R&D opportunities

YOU MAY:
- Discuss how source company capabilities address target's innovation & collaboration needs
- Mention partnership implications specific to innovation & collaboration
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique innovation & collaboration insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB12':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use customer segments, patient demographics
- Instead of repeating <10%: Use market research data, engagement metrics
- Fresh evidence: Customer insights, market segmentation, unmet needs

TASK: Generate Customer Market Insights section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Customer landscape and market segmentation
- Cluster 2: Engagement challenges and market access gaps
- Cluster 3: Customer-centric partnership value
- Cluster 4: Market entry timeline and commercial leadership

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Customer & Market Insights section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Market share comparisons (Company Overview section)
   - Revenue opportunities/risks (Financial/Operational sections)
   - Distribution infrastructure (Company Overview section)
   - Executive mandates (Leadership section)
   - Regulatory deadlines (Operational Risks section)

ALLOWED METRICS for THIS section:
   - Customer segmentation data
   - Satisfaction and engagement metrics
   - Market research capabilities
   - Voice of customer insights

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to customer & market insights.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: Combined customer value proposition

YOU MAY:
- Discuss how source company capabilities address target's customer & market insights needs
- Mention partnership implications specific to customer & market insights
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique customer & market insights insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB13':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use market growth projections, trend data
- Instead of repeating <10%: Use emerging technology adoption, future positioning
- Fresh evidence: Future market dynamics, positioning gaps, strategic outlook

TASK: Generate Emerging Trends Strategic Outlook section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Market trends and future landscape evolution
- Cluster 2: Strategic positioning gaps and future-readiness
- Cluster 3: Partnership trend alignment and foresight value
- Cluster 4: Strategic planning timeline and foresight leadership

CONTENT PRESERVATION (CRITICAL):
Include ALL metrics, percentages, dollar amounts from intelligence
Include ALL dates, quarters, deadlines from intelligence
Name ALL executives, roles, departments from intelligence
Preserve ALL citations [X] from intelligence data exactly
Include ALL competitive benchmarks and company comparisons
Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no emojis)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
- Rewrite or paraphrase unnecessarily
- Drop any quantitative data
- Remove or alter citations
- Describe {$source_company_name} back to itself
- Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO - don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES - add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: "potentially", "projected", "estimated"

Examples:

BAD: "Partnership represents 500M opportunity [X]"
   Problem: No source for 500M figure

GOOD: "Partnership represents 500M opportunity [12]" (with real citation)
OR: Remove claim if no source
OR: "Partnership could represent significant market opportunity" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation - remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Emerging Trends section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - ViiV 32% market share (Company Overview, Market Positioning only)
   - 500M opportunity (Financial, Growth only)
   - 160M revenue risk (Operational Risks only)
   - 275 distribution centers (Company Overview only)
   - CEO Joaquin Duato mandate (Leadership only)
   - 15M additional patients (Growth Opportunities only)

ALLOWED METRICS for THIS section:
   - 52B market by 2034 (shared with Market Positioning)
   - Emerging technology trends
   - Future regulatory landscape
   - Industry disruption patterns
   - Long-horizon market evolution

BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

BAD (Repetitive):
Paragraph: "Emerging AI diagnostics could reshape early detection..."
Bullets:
- AI is changing diagnostics
- Early detection is improving

GOOD (Additive):
Paragraph: "Emerging AI diagnostics could reshape early detection..."
Bullets:
- FDA approved 47 AI-based diagnostic tools in 2024 [89]
- Market projected to reach 8.3B by 2028 [112]
- J&J invested 340M in diagnostic AI partnerships [156]

LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED: "strategic alignment", "synergies", "compelling opportunity"
REPLACEMENT: "mRNA manufacturing capacity expansion to 2B doses by 2027 [134]"

PARTNERSHIP CONTEXT FOR THIS SECTION:

ALLOWED: How ViiV's capabilities position against emerging trends
ALLOWED: Trend-specific foresight advantages
NOT ALLOWED: Generic "partnership creates value" statements
NOT ALLOWED: Repeating same metrics as other sections


CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.


Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB14':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use specific opportunity values, patient reach
- Instead of repeating <10%: Use revenue potential, market expansion data
- Fresh evidence: Partnership value propositions, growth opportunities

TASK: Generate Growth Opportunities section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Growth strategy and market expansion priorities
- Cluster 2: Geographic penetration gaps and execution challenges
- Cluster 3: Partnership growth acceleration value
- Cluster 4: Growth timeline and expansion leadership

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Growth Opportunities section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Market share comparisons (Company Overview section)
   - Distribution infrastructure (Company Overview section)
   - Executive mandates (Leadership section)
   - Regulatory deadlines (Operational Risks section)

ALLOWED METRICS for THIS section:
   - Patient reach projections
   - Growth scenarios and expansion opportunities
   - Specific partnership value propositions
   - Revenue growth potential

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to growth opportunities.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: Specific partnership value propositions for growth

YOU MAY:
- Discuss how source company capabilities address target's growth opportunities needs
- Mention partnership implications specific to growth opportunities
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique growth opportunities insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            case 'NB15':
                $task_instruction = <<<EOT
MANDATORY QUALITY CHECK:
Before writing, verify:
‚ñ° This section will NOT use: synergy, strategic alignment, compelling opportunity
‚ñ° If 32% or <10% was already used in Exec Summary, I'll use different metrics here
‚ñ° Each bullet will add NEW specific data (numbers/dates) not in the paragraph

Metric alternatives for this section:
- Instead of repeating 32%: Use engagement timelines, decision checkpoints
- Instead of repeating <10%: Use next steps, executive contacts
- Fresh evidence: Partnership pathways, action items, accountability

TASK: Generate Engagement Pathways Closing section analyzing {$target_company_name}.

FORMAT: Create 2-5 Insight Clusters. Each cluster has:
1. <p><b>Bold insight sentence</b></p> (high-value summary)
2. <p>Strategic analysis paragraph (explain why this matters, connect implications)</p>
3. <ul><li>Fact list with 2-6 plain bullets (specific data points)</li></ul>

INSIGHT CLUSTERS - Organize intelligence into logical groups:
- Cluster 1: Partnership urgency and engagement framework
- Cluster 2: Collaboration readiness and infrastructure needs
- Cluster 3: Engagement value proposition and strategic fit
- Cluster 4: Activation timeline and executive sponsors

CONTENT PRESERVATION (CRITICAL):
‚úÖ Include ALL metrics, percentages, dollar amounts from intelligence
‚úÖ Include ALL dates, quarters, deadlines from intelligence
‚úÖ Name ALL executives, roles, departments from intelligence
‚úÖ Preserve ALL citations [X] from intelligence data exactly
‚úÖ Include ALL competitive benchmarks and company comparisons
‚úÖ Maintain strategic focus on gaps, risks, opportunities, urgency

FACT LIST FORMAT:
- Plain bullets only (- character)
- NO icons (no üìå)
- NO headers (no 'Fact Card 1:' or 'Fact 1:')
- NO numbering (unless logically needed)
- Each bullet contains specific data: metric, date, executive, benchmark
- Include citations [X] where data was cited

DO NOT:
‚ùå Rewrite or paraphrase unnecessarily
‚ùå Drop any quantitative data
‚ùå Remove or alter citations
‚ùå Describe {$source_company_name} back to itself
‚ùå Add content not in intelligence data


FACT LIST REQUIREMENTS - CRITICAL:

Fact bullets must provide NEW supporting evidence NOT stated in the paragraph above.

DO NOT repeat or restate what's already in the paragraph. Facts are EVIDENCE, not SUMMARY.

‚úÖ GOOD FACTS: Specific numbers, dates, timelines, competitive benchmarks, executive mandates, market data
‚ùå BAD FACTS: Restating paragraph claims, generic observations, vague references

CRITICAL THINKING: Ask "If I removed this bullet, would reader lose NEW info?" If NO ‚Üí don't include.

CONTENT QUALITY REQUIREMENTS - CRITICAL:

Every insight must be SPECIFIC and QUANTIFIED. Generic statements are not acceptable.

‚úÖ SPECIFIC: Dollar amounts, percentages, metrics, named competitors, named executives, specific dates, operational metrics
‚ùå GENERIC: Vague process statements, abstract opportunities, generic challenges

QUALITY TEST: Ask "Could this apply to ANY pharmaceutical partnership?" If YES ‚Üí add specifics.

STRATEGIC vs PROCESS: Focus on WHAT'S AT STAKE (gaps/risks/impacts) not HOW to manage it.

RULE: Every bold insight must identify specific gap/risk/opportunity AND quantified impact.



CITATION REQUIREMENT - CRITICAL:

ALL factual claims must have valid citation references [1], [2], [3], etc.

‚ùå NEVER use [X] as a citation.

If the intelligence data does not provide a source for a claim:
1. DO NOT make the claim
2. OR rephrase to be less specific
3. OR use conditional language: \"potentially\", \"projected\", \"estimated\"

Examples:

‚ùå BAD: \"Partnership represents \$500M opportunity [X]\"
   Problem: No source for \$500M figure

‚úÖ GOOD: \"Partnership represents \$500M opportunity [12]\" (with real citation)
OR: Remove claim if no source
OR: \"Partnership could represent significant market opportunity\" (conditional)

VALIDATION: Before generating ANY statistic, check for citation in intelligence data.
If no citation ‚Üí remove claim or make conditional.

[X] citations are NOT ACCEPTABLE in final output.


EXAMPLE OUTPUT (exact HTML format to return):

<p><b>First Insight Cluster Bold Sentence</b></p>

<p>Strategic analysis paragraph explaining why this matters, with all relevant citations [1][2] integrated in the flowing text.</p>

<ul>
<li>Specific fact with metric or date</li>
<li>Another fact with citation [4]</li>
<li>Third fact with executive name or benchmark</li>
<li>Additional facts as needed (2-6 per cluster)</li>
</ul>

<p><b>Second Insight Cluster Bold Sentence</b></p>

<p>Analysis paragraph for second cluster...</p>

<ul>
<li>Fact bullet for second cluster</li>
<li>Another fact bullet</li>
</ul>

[Repeat for 2-5 total clusters]




ANTI-REDUNDANCY REQUIREMENT - CRITICAL:

Each major metric should appear in MAXIMUM 2 sections across the entire report.

Reserved metrics by section (DO NOT use these metrics if not assigned to your section):
- ViiV's 32% market share ‚Üí Company Overview, Market Positioning ONLY
- J&J's <10% HIV share ‚Üí Company Overview, Market Positioning ONLY
- $500M opportunity ‚Üí Financial Performance, Growth Opportunities ONLY
- $160M revenue risk ‚Üí Operational Risks ONLY
- 15M additional patients ‚Üí Growth Opportunities ONLY
- $52B market by 2034 ‚Üí Market Positioning, Emerging Trends ONLY
- CEO Joaquin Duato mandate ‚Üí Leadership & Governance ONLY
- CFO Jessica Moore ‚Üí Financial Performance ONLY
- Q3 2026 payer downgrades ‚Üí Operational Risks ONLY
- 14-18 month development lag ‚Üí Operational Risks, Innovation ONLY
- 275 distribution centers ‚Üí Company Overview ONLY
- Cabotegravir 47 markets ‚Üí Company Overview, Market Positioning ONLY

If you're tempted to use these metrics in THIS section and they're not assigned here:
‚Üí FIND DIFFERENT FACTS from your intelligence data
‚Üí Your section must provide UNIQUE insights using different data points
‚Üí There are 250+ citations available - use ones not yet emphasized



FACT BULLET ADDITIVE REQUIREMENT - CRITICAL:

Your fact bullets MUST provide NEW information that EXTENDS the paragraph, not restates it.

‚ùå BAD (Repetitive - bullets restate paragraph):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- J&J operates across multiple sectors
- The company's diverse structure supports stability

‚úÖ GOOD (Additive - bullets provide new evidence):
Paragraph: "J&J's diversified portfolio supports stability across market segments..."
Bullets:
- Pharmaceutical division: $52B revenue (55% of total) [45]
- Medical devices division: $27B revenue (29% of total) [78]
- Consumer health division: $15B revenue (16% of total) [112]
- Operating margin maintained at 38% despite sector volatility [158]

Each bullet should provide:
- Specific metrics with citations NOT mentioned in paragraph
- Names of executives or programs NOT mentioned in paragraph
- Dates and timelines NOT mentioned in paragraph
- Competitive comparisons NOT mentioned in paragraph

TEST: If the bullet just confirms what the paragraph said, DELETE it and find new data.



SPECIFICITY REQUIREMENT - BANNED PHRASES:

Replace generic jargon with specific, measurable insights.

‚ùå BANNED PHRASES (never use these):
- "Strategic alignment"
- "Powerful synergies"
- "Compelling opportunity"
- "Collaborative value creation"
- "Patient-centric solutions"
- "Global health outcomes"
- "Competitive positioning"
- "Market leadership"
- "Operational excellence"
- "Value proposition"
- "Key stakeholders"
- "Best practices"

‚úÖ USE INSTEAD (specific and measurable):
- "Manufacturing utilization at 67% vs optimal 85% target"
- "CFO Jessica Moore tied 2026 executive bonuses to partnership ROI metrics"
- "Q3 2026 payer tier downgrades threaten $160M in annual Medicaid revenue"
- "14-18 month CAR-T manufacturing cycle vs Merck's 9-11 months"
- "275 distribution centers across 60 countries enabling 48-hour delivery"

Every insight cluster must include at least 3 specific, measurable facts with citations.
If you catch yourself writing generic language, STOP and find specific data from intelligence.



ANTI-REDUNDANCY RULES - METRICS FOR THIS SECTION:

This is the Engagement Pathways section. Use UNIQUE data specific to this domain.

FORBIDDEN METRICS (assigned to other sections - DO NOT USE):
   - Introducing new metrics (this section synthesizes)

ALLOWED METRICS for THIS section:
   - Recap key partnership value points
   - Engagement timelines and windows
   - Next steps and action items
   - Key decision-makers to engage

If you need metrics from the forbidden list, you are writing content for the wrong section.
Find DIFFERENT data from your intelligence sources specific to engagement pathways.


BULLET POINT REQUIREMENT - MUST ADD NEW INFORMATION:

Generate 4-5 bullet points per insight cluster. These bullets MUST provide NEW,
specific data that SUPPORTS but does NOT RESTATE the paragraph content.

BAD (Repetitive - bullets restate paragraph):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Target operates across multiple sectors
- The company has diverse revenue streams

GOOD (Additive - bullets provide new evidence):
Paragraph: Target's diversified portfolio provides stability across market segments...
Bullets:
- Pharmaceutical division grew 12% YoY despite patent cliff on lead product [citation]
- Medical devices segment faces 15% pricing pressure from payer negotiations [citation]
- Consumer health divestiture reduced revenue volatility by 8% in Q2 2024 [citation]
- Operating margin expanded 2.3 percentage points through cost optimization [citation]

Each bullet should include:
- Specific metrics (percentages, dollar amounts, counts)
- Growth rates or YoY changes
- Named products, executives, programs, or initiatives
- Competitive benchmarks vs named competitors
- Temporal data with quarters/years
- Citations [X]


LANGUAGE QUALITY REQUIREMENT - NO GENERIC JARGON:

BANNED PHRASES (never use these):
- strategic alignment - Use specific: Target's oncology focus complements source's immunology pipeline
- synergies - Use specific: Combined R&D could reduce development costs by 23%
- compelling opportunity - Use specific: Represents a specific dollar amount revenue potential
- collaborative value - Use specific: Joint ventures reduced time-to-market 40%
- complementary strengths - Use specific: Source's distribution centers plus target's expertise
- patient-centric solutions - Use specific: Programs reaching X million patients
- global health outcomes - Use specific: Reduced mortality by X% in Y region

USE SPECIFIC LANGUAGE:
- Exact figures: 67% facility utilization vs optimal 85%
- Named executives: CFO Jessica Moore tied bonuses to partnership ROI
- Specific timelines: Q3 2026 payer downgrades threaten specific amount annually
- Competitive comparisons: 14-18 month lag vs competitor's 9-11 months
- Concrete capabilities: 8 blockbuster drugs each generating over a specific amount annually


PARTNERSHIP CONTEXT FOR THIS SECTION:

Focus: Partnership activation roadmap

YOU MAY:
- Discuss how source company capabilities address target's engagement pathways needs
- Mention partnership implications specific to engagement pathways
- Reference specific source company capabilities (not generic expertise)

DO NOT:
- Repeat identical partnership thesis from other sections
- Use generic partnership advocacy language
- Discuss partnership aspects covered by other sections

Focus on THIS section's unique engagement pathways insights.



CITATION DIVERSITY REQUIREMENT - CRITICAL:

You MUST use citations distributed across the FULL available range, not just early citations [1-20].

‚úÖ GOOD: Citations spanning the entire dataset [1, 15, 34, 67, 102, 178, 245]
‚ùå BAD: Only using early citations [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]

BEFORE writing each insight cluster, actively check: "Am I using citations from different parts of the available range?"

Why this matters:
- The intelligence data contains 200+ citations covering diverse sources
- Using only [1-20] means you're ignoring 90% of available intelligence
- Diverse citation usage = comprehensive analysis drawing from all evidence

Target distribution:
- Use citations from early range [1-50]: ~40% of citations
- Use citations from middle range [51-150]: ~30% of citations
- Use citations from later range [151-253]: ~30% of citations

This ensures you're drawing from ALL available intelligence data, not just the first few sources that appear in the prompt.



Return ONLY valid HTML in this exact structure. Each cluster must have <p><b>Bold sentence</b></p> then <p>paragraph</p> then <ul><li>bullets</li></ul>. Preserve all citations, metrics, dates, and executives from the intelligence data.
EOT;
                break;

            default:
                // Should never reach here - all 15 sections are explicitly handled
                $this->log_trace($runid, 'synthesis', "[M3.5 Phase 3] Unknown section {$nb_code} - this should not happen");
                return null;
        }

        // Combine prompt components (each section's task_instruction has complete formatting requirements)
        $prompt = $base_context . "\n\n" . $task_instruction;

        try {
            // Call OpenAI API (using synthesis_engine's method)
            $api_key = get_config('local_customerintel', 'openaiapikey');
            if (empty($api_key)) {
                throw new \Exception('OpenAI API key not configured');
            }

            $ch = curl_init('https://api.openai.com/v1/chat/completions');
            curl_setopt($ch, CURLOPT_RETURNTRANSFER, true);
            curl_setopt($ch, CURLOPT_POST, true);
            curl_setopt($ch, CURLOPT_HTTPHEADER, [
                'Content-Type: application/json',
                'Authorization: Bearer ' . $api_key
            ]);
            curl_setopt($ch, CURLOPT_POSTFIELDS, json_encode([
                'model' => 'gpt-4o',
                'messages' => [
                    [
                        'role' => 'system',
                        'content' => 'You are an executive intelligence analyst producing strategic opportunity briefs for B2B partnerships. You write in an authoritative, analytical, evidence-backed style. You quantify performance gaps with specific metrics and tie opportunities to executive accountability and urgency.'
                    ],
                    [
                        'role' => 'user',
                        'content' => $prompt
                    ]
                ],
                'temperature' => 0.7,
                'max_tokens' => 1500
            ]));

            $response = curl_exec($ch);
            $http_code = curl_getinfo($ch, CURLINFO_HTTP_CODE);
            curl_close($ch);

            if ($http_code !== 200) {
                throw new \Exception("OpenAI API returned HTTP {$http_code}");
            }

            $data = json_decode($response, true);
            if (json_last_error() !== JSON_ERROR_NONE) {
                throw new \Exception('Invalid JSON response from OpenAI');
            }

            if (!isset($data['choices'][0]['message']['content'])) {
                throw new \Exception('Invalid OpenAI response structure');
            }

            $formatted_html = trim($data['choices'][0]['message']['content']);

            // Clean markdown artifacts
            $formatted_html = preg_replace('/```html\s*/i', '', $formatted_html);
            $formatted_html = preg_replace('/```\s*$/i', '', $formatted_html);
            $formatted_html = trim($formatted_html);

            // M3: Apply three-layer cleanup for stray periods (following M2.1 pattern)
            $formatted_html = str_replace('<p>.</p>', '', $formatted_html);
            $formatted_html = preg_replace('/<p[^>]*>\s*\.\s*<\/p>/i', '', $formatted_html);
            $formatted_html = preg_replace('/>\s*\.\s*<hr/i', '><hr', $formatted_html);
            $formatted_html = trim($formatted_html);

            // Validate HTML structure
            if (!$this->validate_section_html($formatted_html, $nb_code, $runid)) {
                throw new \Exception('HTML validation failed');
            }

            $this->log_trace($runid, 'synthesis', "[M3.5 Phase 2] Successfully generated V3 format for {$nb_code}");
            return $formatted_html;

        } catch (\Exception $e) {
            $this->log_trace($runid, 'synthesis', "[M3.5 Phase 2] Error generating {$nb_code}: " . $e->getMessage());
            error_log("[M3.5 Phase 2] Run {$runid} section {$nb_code} formatting failed: " . $e->getMessage());
            return null; // Graceful fallback - don't break pipeline
        }
    }

    /**
     * M3 Task 3.1: Validate HTML structure for formatted section
     *
     * Ensures:
     * - All tags properly closed
     * - Only allowed CSS classes used (highlight, fact-grid, fact)
     * - Max 1 highlight, 1 fact-grid, 1 bullet list per section
     * - No dangerous HTML (script, iframe, javascript, etc.)
     *
     * @param string $html HTML to validate
     * @param string $nb_code NB code for logging
     * @param int $runid Run ID for logging
     * @return bool True if valid, false otherwise
     */
    private function validate_section_html($html, $nb_code, $runid) {
        // Check for dangerous tags/attributes
        $dangerous = ['<script', '<iframe', '<object', 'javascript:', 'onclick=', 'onerror=', 'onload='];
        foreach ($dangerous as $tag) {
            if (stripos($html, $tag) !== false) {
                $this->log_trace($runid, 'synthesis', "[M3] Section {$nb_code} validation failed: Dangerous HTML detected ({$tag})");
                return false;
            }
        }

        // Check tag closure (basic validation)
        $tag_pairs = [
            ['<div', '</div>'],
            ['<p>', '</p>'],
            ['<ul', '</ul>'],
            ['<li>', '</li>'],
            ['<strong>', '</strong>']
        ];

        foreach ($tag_pairs as list($open, $close)) {
            $open_count = substr_count($html, $open);
            $close_count = substr_count($html, $close);
            if ($open_count !== $close_count) {
                $this->log_trace($runid, 'synthesis', "[M3] Section {$nb_code} validation failed: Unclosed {$open} tags (open: {$open_count}, close: {$close_count})");
                return false;
            }
        }

        // CSS class and component constraint validation disabled for Insight Clusters format
        // Insight Clusters format uses:
        // - Multiple <ul> lists (one per cluster) - so no limit on lists
        // - Semantic HTML only (<p>, <b>, <ul>, <li>) - no CSS classes required
        // - No highlight/fact-grid classes from old format

        $this->log_trace($runid, 'synthesis', "[M3] Section {$nb_code} validation passed");
        return true;
    }
}
